Pulmonary sarcomatoid carcinoma: progress, treatment and expectations

Pulmonary sarcomatoid carcinoma (PSC) is a unique, highly invasive pulmonary malignancy with a poor prognosis, representing 0.1–0.4% of all malignant lung tumors. Because of its highly aggressive character and propensity for frequent metastasis, PSC shows low response rates to traditional treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Wu, Di, Liu, Hongyu, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450456/
https://www.ncbi.nlm.nih.gov/pubmed/32922522
http://dx.doi.org/10.1177/1758835920950207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450456/
https://www.ncbi.nlm.nih.gov/pubmed/32922522
http://dx.doi.org/10.1177/1758835920950207

Ejemplares similares